Scott Rottinghaus
Technik-/Wissenschafts-/F&E-Leiter bei ENANTA PHARMACEUTICALS, INC.
Vermögen: 353 022 $ am 30.04.2024
Aktive Positionen von Scott Rottinghaus
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.08.2022 | - |
Karriereverlauf von Scott Rottinghaus
Ehemalige bekannte Positionen von Scott Rottinghaus
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Scott Rottinghaus
| Mayo Medical School | Doctorate Degree |
| University of Cambridge | Graduate Degree |
| Kansas State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| 2 | |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Scott Rottinghaus
- Erfahrung
